Skip to main content

Advertisement

ADVERTISEMENT

Interviews

Headshot of Dr Michael Stearns, Wolters Kluwer, Health Language
Interview
03/10/2022
Michael Stearns, MD, CPC, CRC, CFPC, specialized consulting director of medical informatics, Wolters Kluwer, Health Language, breaks down how payers must approach risk adjustment factor scores differently after the pandemic disrupted regular...
Michael Stearns, MD, CPC, CRC, CFPC, specialized consulting director of medical informatics, Wolters Kluwer, Health Language, breaks down how payers must approach risk adjustment factor scores differently after the pandemic disrupted regular...
Michael Stearns, MD, CPC, CRC,...
03/10/2022
First Report Managed Care
Headshot of Edmund Pezalla, Enlightenment Bioconsult, LLC
Interview
02/25/2022
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, discusses payer strategies for covering various treatment regimens for HIV.
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, discusses payer strategies for covering various treatment regimens for HIV.
Ed Pezalla, MD, MPH, chief...
02/25/2022
First Report Managed Care

Advertisement

Headshot of Monica Gandhi, UCSF Ward 86, Center of AIDS Research
Interview
11/18/2021
Monica Gandhi, MD, MPH, infectious disease doctor and director of the Center for AIDS Research at University of California–San Francisco, discusses how social determinants of health impact a patient’s ability to access HIV care and...
Monica Gandhi, MD, MPH, infectious disease doctor and director of the Center for AIDS Research at University of California–San Francisco, discusses how social determinants of health impact a patient’s ability to access HIV care and...
Monica Gandhi, MD, MPH,...
11/18/2021
First Report Managed Care
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM)
Conference Coverage
10/27/2021
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM), offers insight into the unique challenges high deductible health plans present for rheumatology patients and shares what she wished...
Andrea Zlatkus, CMPM, CRMS, CRHC, executive director, National Organization of Rheumatology Management (NORM), offers insight into the unique challenges high deductible health plans present for rheumatology patients and shares what she wished...
Andrea Zlatkus, CMPM, CRMS,...
10/27/2021
First Report Managed Care
Headshot of Scott Collins, Chris Hobson, Jim Sdoia, Matthew Michela on a blue background underneath the PopHealth Perspectives logo.
Roundtable
10/05/2021
In this roundtable, Scott Collins, president of marketing at ARIA, moderates a conversation with Matthew A Michela, MBA, president and chief executive officer of Life Image; Chris Hobson, MD, MBA, chief medical officer of Orion Health; and...
In this roundtable, Scott Collins, president of marketing at ARIA, moderates a conversation with Matthew A Michela, MBA, president and chief executive officer of Life Image; Chris Hobson, MD, MBA, chief medical officer of Orion Health; and...
In this roundtable, Scott...
10/05/2021
Integrated Healthcare Executive

Advertisement

Jacqueline Pesa, PhD, director, population health research, Janssen Scientific Affairs
Interview
08/12/2021
Jacqueline Pesa, PhD, director, population health research, Janssen Scientific Affairs, discusses recent research presented at the American Psychiatric Association annual meeting, and explains why providers should educate patients about...
Jacqueline Pesa, PhD, director, population health research, Janssen Scientific Affairs, discusses recent research presented at the American Psychiatric Association annual meeting, and explains why providers should educate patients about...
Jacqueline Pesa, PhD, director,...
08/12/2021
First Report Managed Care
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA
Interview
08/09/2021
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA, explain the differences in how ambulatory quality calculations vary when using data from a single electronic...
John D’Amore, cofounder, board member, and strategic advisor for Diameter Health, and Laura McCrary, EdD, president and CEO of KONZA, explain the differences in how ambulatory quality calculations vary when using data from a single electronic...
John D’Amore, cofounder, board...
08/09/2021
First Report Managed Care
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
08/09/2021
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health

Advertisement

Interview
07/22/2021
Anne M Neilan, MD, MPH, medicine and pediatrics-trained adult infectious disease physician at Massachusetts General Hospital and instructor at Harvard Medical School, explains the results of her recent study that examined the impact of a...
Anne M Neilan, MD, MPH, medicine and pediatrics-trained adult infectious disease physician at Massachusetts General Hospital and instructor at Harvard Medical School, explains the results of her recent study that examined the impact of a...
Anne M Neilan, MD, MPH, medicine...
07/22/2021
First Report Managed Care
Interview
07/08/2021
Matthew R Price, MBA, executive vice president and chief operating officer, Phosplatin Therapeutics, discusses the current pipeline of treatments at Phosplatin—highlighting their lead candidate, PT-112—and explains how they will engage with...
Matthew R Price, MBA, executive vice president and chief operating officer, Phosplatin Therapeutics, discusses the current pipeline of treatments at Phosplatin—highlighting their lead candidate, PT-112—and explains how they will engage with...
Matthew R Price, MBA, executive...
07/08/2021
First Report Managed Care

Advertisement